MXPA01002674A - Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional. - Google Patents

Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.

Info

Publication number
MXPA01002674A
MXPA01002674A MXPA01002674A MXPA01002674A MXPA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A
Authority
MX
Mexico
Prior art keywords
protein
mhc
cell
process according
functional
Prior art date
Application number
MXPA01002674A
Other languages
English (en)
Spanish (es)
Inventor
Ostergaard Pedersen Lars
Original Assignee
Ostergaard Pedersen Lars
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ostergaard Pedersen Lars filed Critical Ostergaard Pedersen Lars
Publication of MXPA01002674A publication Critical patent/MXPA01002674A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA01002674A 1998-09-14 1999-09-14 Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional. MXPA01002674A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801155 1998-09-14
PCT/DK1999/000484 WO2000015665A2 (en) 1998-09-14 1999-09-14 A method of producing a functional immunoglobulin superfamily protein

Publications (1)

Publication Number Publication Date
MXPA01002674A true MXPA01002674A (es) 2002-06-04

Family

ID=8101632

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01002674A MXPA01002674A (es) 1998-09-14 1999-09-14 Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.

Country Status (10)

Country Link
EP (1) EP1114063A2 (ja)
JP (1) JP2002524104A (ja)
KR (1) KR20010075108A (ja)
CN (1) CN1326466A (ja)
AU (1) AU771239C (ja)
BR (1) BR9914491A (ja)
CA (1) CA2343313A1 (ja)
MX (1) MXPA01002674A (ja)
NZ (1) NZ511031A (ja)
WO (1) WO2000015665A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2747357T3 (es) 2001-03-14 2020-03-10 Dako Denmark As Construcciones de moléculas MHC y sus usos para el diagnóstico y terapia
WO2003097669A2 (en) * 2002-05-17 2003-11-27 Københavns Universitet Method for purifying denatured proteins having a desired disulfide bond configuration
US20040072262A1 (en) 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2004072112A2 (en) * 2003-02-11 2004-08-26 Københavns Universitet A method for formulating mhc-like molecules for long time storage
EP1706720A4 (en) * 2003-10-31 2007-02-28 Vitatex Inc BLOOD TEST PROTOTYPES AND METHOD FOR DETECTING CIRCULATING TUMOR AND ENDOTHELIAL CELLS
US7678379B2 (en) 2004-06-17 2010-03-16 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
DE602005022082D1 (de) 2004-08-19 2010-08-12 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
CL2007002225A1 (es) * 2006-08-03 2008-04-18 Astrazeneca Ab Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
TWI445544B (zh) 2007-05-01 2014-07-21 Biogen Idec Inc 增進血管形成之組合物及方法
EP3023436A1 (en) 2007-07-03 2016-05-25 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
DE17196350T1 (de) 2007-07-09 2018-12-27 Genentech, Inc. Verhindern der disulfid-bindungsreduktion während der rekombinanten herstellung von polypeptiden
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
CN103364558A (zh) * 2013-07-17 2013-10-23 江阴泽成生物技术有限公司 一种人肿瘤标志物癌胚抗原（cea）的磁微粒化学发光免疫分析试剂盒及其检测方法
CN109402036A (zh) * 2018-11-07 2019-03-01 河北科技师范学院 牛源肠炎沙门菌trxB基因缺失的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
WO1993022332A2 (en) * 1992-04-24 1993-11-11 Board Of Regents, The University Of Texas System Recombinant production of immunoglobulin-like domains in prokaryotic cells
WO1994006813A1 (en) * 1992-09-15 1994-03-31 The Rockefeller University Major histocompatibility complex molecules and modifications thereof
EP0726777A4 (en) * 1993-10-25 2002-04-24 Anergen Inc Procarciotic expression of MHC proteins
AU3036597A (en) * 1996-05-21 1997-12-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells

Also Published As

Publication number Publication date
WO2000015665A2 (en) 2000-03-23
WO2000015665A3 (en) 2000-08-17
AU771239C (en) 2004-10-14
EP1114063A2 (en) 2001-07-11
JP2002524104A (ja) 2002-08-06
AU5504799A (en) 2000-04-03
KR20010075108A (ko) 2001-08-09
CA2343313A1 (en) 2000-03-23
BR9914491A (pt) 2002-01-15
AU771239B2 (en) 2004-03-18
NZ511031A (en) 2003-11-28
CN1326466A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
MXPA01002674A (es) Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.
West et al. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells
Frayser et al. Empty and Peptide-Loaded Class II Major Histocompatibility Complex Proteins Produced by Expression inEscherichia coliand Foldingin Vitro
DE69833949T2 (de) Mutierte klasse-i-mhc-moleküle
EP1844072B1 (en) Mhc oligomer and method of making the same
US20240294601A1 (en) Peptide deficient-mhc class i/chaperone compositions and methods
Parker et al. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.
EP1882700B1 (en) Biotinylated MHC complexes and their uses
Ignatowicz et al. Cell surface expression of class II MHC proteins bound by a single peptide.
JP2004503213A (ja) １本鎖クラスｉ主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
CA3095741A1 (en) Peptide-mhc compacts
Hochman et al. Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.
US20090028884A1 (en) Oligomeric receptor ligand pair member complexes
Purcell et al. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design
JP2004524019A (ja) 内因性蛍光自己多量体化ｍｈｃ融合タンパク質およびその複合体
JP2008528484A (ja) 分子間の非共有的結合性相互作用の破壊のための手段および方法
CN114174329A (zh) 肽-mhc复合物
CA2308463A1 (en) Cd8 as an inhibitor of the cellular immune system
US11814420B2 (en) Peptide deficient-MHC class I/chaperone compositions and methods
Crumpton et al. Molecular structure of the gene products of the human HLA system: isolation and characterization of HLA-A,-B,-C and Ia antigens
Moro et al. Generation of functional HLA-DR* 1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides
Nag et al. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations
Li et al. Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1
Tussey et al. General introduction to the MHC
US20220275050A1 (en) High yield production and use of enzymatic-exchangeable peptide major histocompatibility complex class i single chain trimer tetramer